BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9464521)

  • 1. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): an accessory role for CR3 during virus entry?
    Stoiber H; Frank I; Spruth M; Schwendinger M; Mullauer B; Windisch JM; Schneider R; Katinger H; Ando I; Dierich MP
    Mol Immunol; 1997; 34(12-13):855-63. PubMed ID: 9464521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis of the Arg-Gly-Asp triplet in human complement component C3 does not abolish binding of iC3b to the leukocyte integrin complement receptor type III (CR3, CD11b/CD18).
    Taniguchi-Sidle A; Isenman DE
    J Biol Chem; 1992 Jan; 267(1):635-43. PubMed ID: 1730624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes.
    Ross GD; Reed W; Dalzell JG; Becker SE; Hogg N
    J Leukoc Biol; 1992 Feb; 51(2):109-17. PubMed ID: 1358992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of complement receptor 3 (CR3) and regulatory protein CD46 on dendritic cells of antiretroviral naïve and treated HIV-1 infected individuals: Correlation with immune activation status.
    Mishra N; Mohata M; Aggarwal H; Chaudhary O; Das BK; Sinha S; Hazarika A; Luthra K
    Mol Immunol; 2018 Apr; 96():83-87. PubMed ID: 29525453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.
    Bartók I; Walport MJ
    J Immunol; 1995 May; 154(10):5367-75. PubMed ID: 7730637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement Receptor 3 Mediates HIV-1 Transcytosis across an Intact Cervical Epithelial Cell Barrier: New Insight into HIV Transmission in Women.
    Day CJ; Hardison RL; Spillings BL; Poole J; Jurcisek JA; Mak J; Jennings MP; Edwards JL
    mBio; 2022 Feb; 13(1):e0217721. PubMed ID: 35012346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the C3 receptor induced by herpes simplex virus type 1 infection of human epidermal, endothelial, and A431 cells.
    Kubota Y; Gaither TA; Cason J; O'Shea JJ; Lawley TJ
    J Immunol; 1987 Feb; 138(4):1137-42. PubMed ID: 3027170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3).
    Malhotra V; Hogg N; Sim RB
    Eur J Immunol; 1986 Sep; 16(9):1117-23. PubMed ID: 3530784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
    Thornton BP; Vĕtvicka V; Pitman M; Goldman RC; Ross GD
    J Immunol; 1996 Feb; 156(3):1235-46. PubMed ID: 8558003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.
    Myones BL; Dalzell JG; Hogg N; Ross GD
    J Clin Invest; 1988 Aug; 82(2):640-51. PubMed ID: 2969921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type lectin-independent interaction of complement opsonized HIV with monocyte-derived dendritic cells.
    Pruenster M; Wilflingseder D; Bánki Z; Ammann CG; Muellauer B; Meyer M; Speth C; Dierich MP; Stoiber H
    Eur J Immunol; 2005 Sep; 35(9):2691-8. PubMed ID: 16094691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells.
    Cywes C; Godenir NL; Hoppe HC; Scholle RR; Steyn LM; Kirsch RE; Ehlers MR
    Infect Immun; 1996 Dec; 64(12):5373-83. PubMed ID: 8945590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonization of HIV with complement enhances infection of dendritic cells and viral transfer to CD4 T cells in a CR3 and DC-SIGN-dependent manner.
    Bouhlal H; Chomont N; Réquena M; Nasreddine N; Saidi H; Legoff J; Kazatchkine MD; Bélec L; Hocini H
    J Immunol; 2007 Jan; 178(2):1086-95. PubMed ID: 17202372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD16 inhibits CR3 (CD11b/CD18)-mediated infection of monocytes/macrophages by opsonized primary R5 HIV-1.
    Bouhlal H; Galon J; Kazatchkine MD; Fridman WH; Sautès-Fridman C; Haeffner Cavaillon N
    J Immunol; 2001 Mar; 166(5):3377-83. PubMed ID: 11207294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
    Ross GD; Cain JA; Lachmann PJ
    J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3.
    Fischer E; Capron M; Prin L; Kusnierz JP; Kazatchkine MD
    Cell Immunol; 1986 Feb; 97(2):297-306. PubMed ID: 3742611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of C3-receptor activity on human B-lymphocytes and isolation of the complement receptor type 2 (CR2).
    Micklem KJ; Sim RB; Sim E
    Biochem J; 1984 Nov; 224(1):75-86. PubMed ID: 6239618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors.
    Galon J; Gauchat JF; Mazières N; Spagnoli R; Storkus W; Lötze M; Bonnefoy JY; Fridman WH; Sautès C
    J Immunol; 1996 Aug; 157(3):1184-92. PubMed ID: 8757624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum.
    Schlesinger LS; Horwitz MA
    J Clin Invest; 1990 Apr; 85(4):1304-14. PubMed ID: 2138634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1.
    Stoiber H; Ebenbichler C; Schneider R; Janatova J; Dierich MP
    AIDS; 1995 Jan; 9(1):19-26. PubMed ID: 7893437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.